IV Antibiotic Ceftobiprole Under Review for Serious Bacterial Infections

The FDA has accepted the New Drug Application for ceftobiprole, a broad spectrum cephalosporin antibiotic for IV administration.

Related Keywords

Marc Engelhardt ,Drug Administration ,New Drug Application ,Chief Medical Officer ,Prescription Drug User Fee Act ,